Pfizer Inc
NYSE: PFE
$26.13
+$0.41 (+1.6%)
Real Time Data Delayed 15 Min.
PFE Articles
Wikimedia CommonsMen, or their significant others, will be able to buy Pfizer Inc.’s (NYSE: PFE) erectile dysfunction drug Viagra online soon. Maybe the big pharmaceutical company figures it is...
Published:
ThinkstockIron Man’s Record Weekend Walt Disney Co.’s (NYSE: DIS) “Iron Man 3” could save the summer box office yield all by itself. Like several serial movie franchises, each installment...
Published:
Jon OggBiotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many investors, what investors need to know...
Published:
Last Updated:
ThinkstockDrug giant Pfizer Inc. (NYSE: PFE) this morning reported adjusted earnings and revenues that missed analysts estimates, and the stock is down more than 3%. Last week competitor Amgen Inc....
Published:
Last Updated:
This week should mark the climax of first quarter corporate earnings season. It will be a full week for the earnings calendar, along with key economic events and some corporate annual meetings to...
Published:
Last Updated:
While the current stock market rally has been impressive since the lows last November, many investors, analysts and equity strategists are casting a wary eye at the looming May 1 date. In a new...
Published:
Last Updated:
courtesy of Facebook Inc.Martha Stewart Omnimedia Inc. (NYSE: MSO) is unable to get a court to dismiss charges by Macy’s Inc. (NYSE: M) that it has exclusive rights to some of her products....
Published:
ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a minimum...
Published:
Jon Ogg24/7 Wall St. wants some insight from readers ahead of earnings season. We have grouped four rival sectors to see which ones investors are more excited about this earnings season. This is a...
Published:
Last Updated:
ThinkstockThe debate over how America’s largest companies use cash will pick up again. Moody’s Investor Services released a study that forecasts how big the cash balances will be at some of...
Published:
ThinkstockCorporate Cash Piles Up The debate over how America’s largest companies use cash will pick up again. Moody’s Investor Services released a study that forecasts how big the cash balances...
Published:
ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that...
Published:
Last Updated:
ThinkstockHave some widely owned health care names hit a wall when it comes to growth and earnings? In a research report issued today, Credit Suisse Group Inc. (NYSE: CS) issues some not very...
Published:
Last Updated:
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AbbVie Inc. (NYSE: ABBV) started as Neutral at Credit Suisse. Akamai...
Published:
ThinkstockCorporate governance issues are sometimes a blessing for shareholders, but they also can crush the rights of shareholders in many cases. Tracking CEO pay of large public companies is now...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.